Literature DB >> 3974442

Infections due to Lancefield group G streptococci.

C Vartian, P I Lerner, D M Shlaes, K V Gopalakrishna.   

Abstract

The group G streptococcus has surfaced in the past 10 to 15 years as an important opportunistic and nosocomial pathogen. Although more precise organism recognition accounts for a portion of these cases, there can be little doubt that the group G streptococcus has become a more prevalent pathogen. Commercial kits, utilizing staphylococcal coagglutination or latex agglutination, are now available, affording all clinical laboratories the opportunity to identify this organism easily. Published reviews encompassing the experiences of a single institution or even several institutions affiliated with a single medical center, particularly as they were influenced by referral patterns, did not reflect the broad scope of infections that we discovered by extending our survey into the community, beyond the medical center complex and its immediate affiliated hospitals. Although malignancy is the single most obvious background factor, alcoholism and diabetes are also important host determinants of infection. Skin and soft-tissue infections (and surface sources of infection) are equally important among patients with or without the element of malignancy. Polymicrobial infection, including polymicrobial bacteremia, is an important feature, with S. aureus infections accounting for most of these cases, relating to the skin and soft tissue sources of infections so commonly seen. We saw a panorama of problems including endocarditis, septic arthritis, pleuropulmonary infections, bone and joint infections, puerperal sepsis and neonatal infection, peritonitis and ophthalmitis; we also saw a significant number of patients with bacteremia and no apparent primary source of infection. Response to antibiotic therapy was dictated by the nature of the underlying diseases, and individuals without a background of malignant disease did well, particularly those with skin and soft-tissue infections. While the literature suggests that patients with endocarditis and septic arthritis due to this organism respond poorly to antibiotic therapy, implying that such failures relate to in vitro antibiotic phenomena, we preferred to examine the problem from the viewpoint of the host(s) involved. Subacute endocarditis and acute endocarditis due to the group G streptococcus may be clinically separable, and thus require separate therapeutic approaches. In patients with septic arthritis, prosthetic devices, prior joint disease and immunosuppressive diseases and therapy often adversely influence the response to antibiotic therapy.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3974442     DOI: 10.1097/00005792-198503000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  33 in total

1.  High-level aminoglycoside resistance in the beta-hemolytic group G Streptococcus isolate BM2721.

Authors:  M Galimand; T Lambert; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci.

Authors:  C M Collins; A Kimura; A L Bisno
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Prevalence and mechanism of resistance to antimicrobial agents in group G streptococcal isolates from China.

Authors:  Jun Yin; Sangjie Yu; Xiaorong Liu; Ye Li; Wei Gao; Xiang Ma; Yonghong Yang
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

Review 4.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

5.  Septicemia caused by Streptococcus canis in a human.

Authors:  F Bert; N Lambert-Zechovsky
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Different erythromycin resistance mechanisms in group C and group G streptococci.

Authors:  J Kataja; H Seppälä; M Skurnik; H Sarkkinen; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Endophthalmitis as presenting symptom of group G streptococcal endocarditis.

Authors:  P E Verweij; A J Rademakers; P P Koopmans; J F Meis
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

8.  Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital.

Authors:  A Bucher; P Gaustad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

9.  Group G streptococcal sepsis, septic arthritis and myositis in a patient with severe oral ulcerations.

Authors:  Wu Deng; Laurie Farricielli
Journal:  BMJ Case Rep       Date:  2014-01-27

Review 10.  Beta haemolytic streptococci and musculoskeletal sepsis in adults.

Authors:  C Deighton
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.